{"id":713139,"date":"2026-09-14T07:56:03","date_gmt":"2026-09-14T07:56:03","guid":{"rendered":"https:\/\/microscopemedia.com\/?p=713139"},"modified":"2026-09-14T07:56:03","modified_gmt":"2026-09-14T07:56:03","slug":"investigatia-acum-disponibila-in-romania-pet-ct-psma","status":"publish","type":"post","link":"https:\/\/microscopemedia.com\/?p=713139","title":{"rendered":"Investiga\u021bia acum disponibil\u0103 \u00een Rom\u00e2nia: PET-CT PSMA"},"content":{"rendered":"<div readability=\"49.617339312407\">\n<div class=\"sgb-google-buttons\">\n<div class=\"display-flex justify-center google-logo\"><img decoding=\"async\" loading=\"lazy\" class=\"mg-x-auto\" width=\"30\" height=\"30\" src=\"https:\/\/microscopemedia.com\/wp-content\/uploads\/2026\/09\/investigatia-acum-disponibila-in-romania-pet-ct-psma.png\" alt><\/div>\n<\/p><\/div>\n<p id=\"p-0\">Investiga\u021bia poate fi recomandat\u0103 pentru stadializarea ini\u021bial\u0103 a bolii, pentru pacien\u021bii cu <a href=\"https:\/\/www.sanador.ro\/cancer-prostata\" target=\"_blank\" rel=\"noopener\">cancer de prostat\u0103<\/a> cu risc \u00eenalt, sau pentru restadializare, atunci c\u00e2nd exist\u0103 suspiciunea de recidiv\u0103 biochimic\u0103 dup\u0103 un tratament cu inten\u021bie curativ\u0103.<\/p>\n<p id=\"p-1\">P\u00e2n\u0103 la introducerea acestei investiga\u021bii avansate \u00een \u021bara noastr\u0103, pacien\u021bii rom\u00e2ni care aveau indica\u021bie pentru PET-CT PSMA o puteau realiza doar \u00een centre medicale din str\u0103in\u0103tate. Procedura permite eviden\u021bierea leziunilor care exprim\u0103 antigen membranar specific prostatic \u2013 <a href=\"https:\/\/www.sanador.ro\/psma\" target=\"_blank\" rel=\"noopener\">PSMA<\/a>, o protein\u0103 prezent\u0103 \u00een cantitate crescut\u0103 pe suprafa\u021ba multor celule ale cancerului de prostat\u0103.<\/p>\n<p id=\"p-2\">Realizarea investiga\u021biei implic\u0103 administrarea intravenoas\u0103 a unui radiotrasor special, care circul\u0103 prin s\u00e2nge \u0219i se leag\u0103 de aceast\u0103 \u021bint\u0103 molecular\u0103, astfel \u00eenc\u00e2t medicii pot identifica \u0219i localiza leziuni PSMA-pozitive. \u00cen acest fel, pot fi identificate leziuni tumorale la nivelul ganglionilor limfatici, oaselor sau altor organe, contribuind semnificativ la evaluarea extinderii bolii.<\/p>\n<p id=\"p-3\">Recomandarea pentru aceast\u0103 investiga\u021bie este stabilit\u0103 individual \u0219i nu \u00eenlocuie\u0219te alte proceduri indicate de medic. Avantajul examin\u0103rii este informa\u021bia suplimentar\u0103 pe care o poate furniza despre localizarea \u0219i extinderea bolii, inclusiv dincolo de prostat\u0103, aspect care poate influen\u021ba, \u00een anumite situa\u021bii, adaptarea planului de tratament. De aceea, rezultatul PET-CT PSMA este discutat de echipa oncologic\u0103 multidisciplinar\u0103 \u00eempreun\u0103 cu alte investiga\u021bii efectuate, pentru stabilirea planului de tratament personalizat.<\/p>\n<p id=\"p-4\">\u00cen unele cazuri de <a href=\"https:\/\/www.sanador.ro\/cancer-prostata-metastatic\" target=\"_blank\" rel=\"noopener\">cancer de prostat\u0103 avansat<\/a>, examinarea poate contribui \u0219i la evaluarea eligibilit\u0103\u021bii pacien\u021bilor pentru terapia PSMA cu lute\u021biu-177. Aceast\u0103 metod\u0103 de tratament este destinat\u0103 unor cazuri atent selectate, \u00een care leziunile exprim\u0103 suficient PSMA \u0219i sunt \u00eendeplinite criteriile medicale pentru tratament.<\/p>\n<p id=\"p-5\">\u0218i terapia PSMA cu lute\u021biu-177 este disponibil\u0103 \u00een premier\u0103 \u00een \u021bara noastr\u0103 la Centrul Oncologic SANADOR, fiind administrat\u0103 \u00een Sec\u021bia de Terapie Izotopic\u0103, special amenajat\u0103 pentru desf\u0103\u0219urarea procedurilor de medicin\u0103 nuclear\u0103 \u00een condi\u021bii de radioprotec\u021bie. \u00cen func\u021bie de indica\u021bia medical\u0103 stabilit\u0103, pacien\u021bii au acces \u0219i la alte metode de tratament pentru cancerul de prostat\u0103, printr-o abordare integrat\u0103 multidisciplinar\u0103.<\/p>\n<p id=\"p-6\">&nbsp;<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Investiga\u021bia poate fi recomandat\u0103 pentru stadializarea ini\u021bial\u0103 a bolii, pentru pacien\u021bii cu cancer de prostat\u0103 cu risc \u00eenalt, sau pentru restadializare, atunci c\u00e2nd exist\u0103 suspiciunea de recidiv\u0103 biochimic\u0103 dup\u0103 un &hellip; <a href=\"https:\/\/microscopemedia.com\/?p=713139\" class=\"more-link\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":713140,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/713139"}],"collection":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=713139"}],"version-history":[{"count":0,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/713139\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/media\/713140"}],"wp:attachment":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=713139"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=713139"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=713139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}